ComEA-mCherry protein, which is indicative of DNA translocation into the periplasm (6) of a predator cell (Fig. 4 and figs. S13 and S14). Similar genetransfer events were never or only rarely observed in the T6SS-negative strain; in the presence of extracellular deoxyribonuclease; if the predator lacked the outer membrane secretin protein PilQ, which is required for efficient DNA uptake (5, 6); or in the absence of any prey (figs. S14 and S15).
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Adipocytes have been suggested to be immunologically active, but their role in host defense is unclear. We observed rapid proliferation of preadipocytes and expansion of the dermal fat layer after infection of the skin by Staphylococcus aureus. Impaired adipogenesis resulted in increased infection as seen in Zfp423 nur12 mice or in mice given inhibitors of peroxisome proliferator-activated receptor g. This host defense function was mediated through the production of cathelicidin antimicrobial peptide from adipocytes because cathelicidin expression was decreased by inhibition of adipogenesis, and adipocytes from Camp −/− mice lost the capacity to inhibit bacterial growth. Together, these findings show that the production of an antimicrobial peptide by adipocytes is an important element for protection against S. aureus infection of the skin.
H ost defense against microbial infection involves the participation of several cell types. Owing to the rapid doubling time of many microbes, immediate protection provided by local resident cells-such as epithelial cells, mast cells, and resident leukocytes-is essential to restrict the spread of infection during the lag period before recruitment of additional cells, such as neutrophils and monocytes (1, 2) . The production of antimicrobial peptides (AMPs) by local resident cells and recruited leukocytes is a key mechanism to limit pathogen growth (3) (4) (5) .
Staphylococcus aureus is a major cause of skin and soft-tissue infections in humans, causing both local and systemic disease (6, 7) . We observed that a large and previously unrecognized expansion of the subcutaneous adipose layer was evident during the early response to S. aureus skin infection (Fig. 1A) . The response to infection was confirmed with quantification of the abundance of adipocytes (Fig. 1B and fig. S1A ), observations of an increase in lipid staining (fig. S1B), and increased activation of the adiponectin promoter as measured in AdipoQcre;R26R mice ( Fig. 1C ) (8) . Adipocytes progressively increased in size after S. aureus infection (Fig. 1B) , suggesting that the expansion of dermal adipose tissue occurs at least in part through hypertrophy of mature adipocytes. PREF1 and ZFP423 mark committed preadipocytes required for adipose tissue development and expansion (9) (10) (11) . Proliferation of these preadipocytes at the site of infection was further confirmed with colocalization of PREF1 and ZFP423 with proliferation markers BrdU (Fig. 1D and fig. S1C ) and Ki67 ( fig. S1D ). Additionally, dermal cells isolated from S. aureusinfected skin exhibited greater adipogenic potential than that of cells isolated from the same amount of uninfected skin, as indicated by lipid production and induction of adipocyte markers Adipoq and Fabp4 in response to adipocyte differentiation medium (Fig. 1E and fig. S1E ). Also supporting the conclusion that infection results in an increase of cells within the dermis with the potential to differentiate into adipocytes were observations of an increase of mRNA and protein for transcription factors driving preadipocyte differentiation, including Cebpb, Pparg, and Cebpa ( Fig. 1F and fig. S1 , D and F) (12, 13) . Peroxisome proliferator-activated receptor-g (PPARg)-positive cells at the infected sites were negative for CD11b ( fig. S1G ), confirming that they were not myeloid cells. To test that cell proliferation was associated with adipocyte formation, we examined BrdU SCIENCE sciencemag.org incorporation within the nuclei of adipocytes after multiple injections of BrdU (14) during the first 3 days after infection. A significant increase in the number of BrdU-positive nuclei was seen within cells from S. aureus-infected mice stained with the adipocyte surface protein Caveolin (Fig.  1G) , thus confirming that adipocytes at the site of infection were at least partially derived from proliferative precursors. Together, these data showed that infection by S. aureus triggers preadipocyte proliferation and expansion of local dermal adipocytes.
We next tested whether adipocyte activation was essential for protection against S. aureus infection using Zfp423 reporter mice and Zfp423 
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mice in which adipogenesis is prominently impared (11, 15) . Activation of Zfp423 during infection was confirmed by visualizing b-Gal staining on the underside of skin from infected Zfp423 lacZ reporter mice ( Fig. 2A) (16) To complement the observations made in Zfp423 nur12 mice, we chemically inhibited adipogenesis by pretreating wild-type mice with bisphenol A diglycidyl ether (BADGE) or GW9662, both pharmacological inhibitors of PPARg and acute chemical inhibitors of adipogenesis (14, 19, 20) . Similarly to Zfp423 nur12 mice, BADGE-or GW9662-treated mice showed decreased adipose expansion after S. aureus infection ( fig. S3A ) and became more susceptible to infection (Fig. 2, F to H, and  fig. S3B ). In BADGE-treated mice, PDGFRa + Sca1 + preadipocyte numbers appeared normal ( fig. S3C ), but PPARg expression decreased ( fig. S3D ), suggesting as in a previous report (14) that inhibition of PPARg impaired dermal adipose growth by blocking preadipocyte differentiation into adipocytes rather than by inhibiting the preadipocyte commitment process. Increased susceptibility to S. aureus in BADGE-treated mice was not caused by defective leukocyte recruitment ( fig. S3E ) nor by any impaired ability of blood neutrophils to kill S. aureus ( fig. S3F ). Because neutrophil function is a major factor in resisting S. aureus skin infection (6) , this finding confirmed that the increased susceptibility to infection observed with PPARg inhibitors was caused by their effect on adipocyte formation.
3T3-L1 cells are a well-characterized primary mouse preadipocyte line that can be induced to differentiate into mature adipocytes (21) . To determine how adipocytes might protect against infection, a comparison of antimicrobial peptide (AMP) gene expression was done in 3T3-L1 undifferentiated preadipocytes (pAds) and differentiated adipocytes (Ads). This showed that mouse cathelicidin antimicrobial peptide (Camp) was strongly induced in Ads compared with pAds, whereas other AMPs belonging to the a-and b-defensin families did not show an increase in expression (Fig. 3A) . Camp mRNA increased at day 1 after differentiation then decreased during later stages of differentiation ( fig. S4A) . Camp expression preceded expression of adipokines Resistin (Retn), Leptin (Lep), and Fabp4, whereas the relative expression of another AMP, Defb14, decreased during differentiation ( fig. S4, B to H) .
Cathelicidin protein peaked at day 2 to~4 after differentiation and was abundantly detectable with Western blotting of cell extracts from differentiating pAds (fig. S4I ). The size of cathelicidin detected by means of Western blot was consistent with the mCAP18 cathelicidin precursor protein (22) . Cathelicidin was also found with Western blotting in adipocyte-conditioned medium (Fig.  3B) . Secretion of cathelicidin protein preceded secretion of Resistin, Leptin, and FABP4 at days 2 to 4 after differentiation (Fig. 3B) and was similar to that of Collagen type-IV (COL4A1), which was produced 1 to 2 days after differentiation (23). Immunostaining of 3T3-L1 cells showed cathelicidin appearing simultaneously with lipid droplets in the cytoplasm of Ads (Fig. 3C) and localized in the early endosome, but not in the lysosome ( fig. S4J ). To verify that cathelicidin was also produced by human adipocytes, we evaluated cultured primary human preadipocytes with reagents directed against human cathelicidin. The CAMP gene was strongly induced during differentiation ( fig. S5A) , and Western blot showed bands consistent with the cathelicidin precursor protein hCAP18 and a shorter peptide (fig. S5B ). This peptide appeared larger than LL-37, the mature peptide form of cathelicidin detected from human neutrophils (24) , thus suggesting adipocytes may have an enzymatic processing system differing from that known in other cell types (25) .
Cathelicidin mRNA was detected in the subcutaneous fat pad from 1-to~2-week-old mice ( fig. S6, A and B) , a stage in which the tissue is undergoing early adipogenesis (26) . Camp mRNA was more abundant in white adipose tissue than brown adipose tissue ( fig. S6C ). Cathelicidin protein immunostaining was detected in fat tissue from mice and humans (Fig. 3C ) and was localized in the early endosome of adipocytes ( fig. S6D) . In a mouse model of diet-induced obesity, Camp mRNA measured with quantitative polymerase chain reaction (PCR) and cathelicidin protein levels estimated by means of Western blot (fig. S7, A and B) were more abundant in the subcutaneous fat pad from mice fed high-fat diet as compared with low-fat diet controls. High-fat diet increased both bone marrow adiposity and cathelicidin protein expression in bone marrow adipocytes ( fig. S7C ). Serum cathelicidin levels were also elevated in the high-fat diet group (Fig. 3D and fig. S7 , D and E), similar to samples from overweight humans [body mass index (BMI) > 25] (Fig. 3E) . The level of cathelicidin detected with enzyme-linked immunosorbent assay in serum (~50 ng/ml) was well below the amount of LL-37 necessary to inhibit S. aureus growth, which is typically above 2 to 5 mg/ml (27) . Thus, the high local expression of cathelicidin is more likely to provide antimicrobial function than is the small increase in systemic cathelicidin found in obesity.
Cathelicidin mRNA production during 3T3-L1 differentiation was significantly enhanced when S. aureus-conditioned medium or ultraviolet (UV)-killed S. aureus was added to adipocyte differentiation medium (Fig. 3F) , revealing that S. aureus directly enhances AMP production during adipocyte differentiation. Similar to 3T3-L1 cells, dermal cells isolated from S. aureus-infected skin, which were shown in Fig. 1E to exhibit high adipogenic potential, produced Camp mRNA and abundant cathelicidin protein preceding the production of FABP4 (Fig. 3G) .
We next examined cathelicidin production during S. aureus infection by immunostaining infected mouse skin. Cathelicidin protein and mRNA were strongly induced in the fat layer at the site of infection (Fig. 4A and fig. S8A ). Cathelicidin protein colocalized with expression of the adiponectin reporter b-Gal in AdipoQ-cre;R26R mice ( fig. S8B) and COL4A1 (fig. S8, C and D) , showing that cathelicidin was expressed in adipocytes in vivo during S. aureus infection, correlating with the increase in dermal adipocytes ( Fig. 1 ) and its expression during early adipogenesis (Fig. 3B) .
The precursor (~18 kD) and a peptide form (5 to~10 kD) of cathelicidin were detected in differentiated 3T3-L1 adipocytes (Fig. 4B ) and in the cell lysate of mouse adipose tissue (Fig. S9A) .
Similarly to cultured human adipocytes, the mouse adipocyte-derived cathelicidin peptide was slightly larger than mature cathelicidin-related antimicrobial peptide (CRAMP) derived from mouse neutrophils. We tested conditioned medium from differentiated 3T3-L1 adipocytes and observed that conditioned medium that contained secreted cathelicidin potently inhibited the growth of S. aureus, whereas conditioned medium from pAds that lacked cathelicidin did not (Fig. 4C) . Brefeldin-A treatment blocked cathelicidin secretion from adipocytes and abolished the antimicrobial activity of the conditioned medium derived from adipocytes ( fig. S9B) . Furthermore, extracts from wild-type mouse adipose tissue inhibited growth of S. aureus (Fig. 4D and fig. S9C ) and Pseudomonas aeruginosa (Fig. S9D) Mice in which adipose expansion was inhibited showed reduced defense against S. aureus infection, and this correlated with reduced cathelicidin. BADGE treatment of 3T3-L1 during differentiation inhibited Pparg and Cebpa mRNA and blocked Camp (fig. S11A) . The expression of cathelicidin was less in mice treated with BADGE ( fig. S11B ) and in Zfp423 nur12 mice (Fig. 4, E and F) , although the expression of cathelicidin seen in cells recruited to the site of infection was maintained. BADGE or dimethyl sulfoxide (ctrl) before infecting with S. aureus and S. aureus survival in skin measured 3 days later (n = 7 to~10 mice/group).
All error bars indicate mean T SEM. *P < 0.05, **P < 0.01, ***P < 0.001 (one-way analysis of variance). Red brackets indicate subcutaneous adipose layer. 
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Relative Camp mRNA abundance no further increase in infection (Fig. 4G and  fig. S12 ), suggesting that the effects of BADGE on cathelicidin production from adipocytes was responsible for the increase in S. aureus infection in vivo. These results show that a local increase in subcutaneous adipocytes is an important host defense response against skin infection. This observation is consistent with prior observations that adipocytes secrete a variety of bioactive adipokines and cytokines that mediate immune responses after injury (28) and now shows that adipocytes produce an AMP that can directly kill bacteria. Local expansion of dermal fat produces cathelicidin in response to infection, but this response appears to decline as adipocytes mature. The expansion of dermal fat in response to infection may also indirectly benefit immune defense by influencing other processes such as neutrophil oxidative burst, thus further amplifying the importance of the subcutaneous preadipocyte pool in preventing infections. Defective AMP production by mature adipocytes may explain observations of elevated susceptibility to infection during obesity and insulin resistance (29) . Cathelicidin has also been shown to be proinflammatory (30) . Therefore, the production of cathelicidin by adipocytes may also participate in the chronic, low-level inflammation observed in obesity (28).
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Enterovirus D68 (EV-D68) is a member of Picornaviridae and is a causative agent of recent outbreaks of respiratory illness in children in the United States. We report here the crystal structures of EV-D68 and its complex with pleconaril, a capsid-binding compound that had been developed as an anti-rhinovirus drug. The hydrophobic drug-binding pocket in viral protein 1 contained density that is consistent with a fatty acid of about 10 carbon atoms. This density could be displaced by pleconaril. We also showed that pleconaril inhibits EV-D68 at a half-maximal effective concentration of 430 nanomolar and might, therefore, be a possible drug candidate to alleviate EV-D68 outbreaks.
P
icornaviruses constitute a large family of small icosahedral viruses with a single positivestranded RNA genome and an external diameter of about 300 Å. The Enterovirus genus includes medically important human pathogens, such as human rhinoviruses (HRVs), polioviruses (PVs) and coxsackieviruses (CVs) (table S1) (1, 2). Many of these enteroviruses (EVs) have been well characterized structurally and functionally (3) (4) (5) (6) (7) (8) (9) (10) . However, the species EV-D remains poorly characterized.
An upsurge of EV-D68 cases in the past few years has shown clusters of infections worldwide (11) . In August 2014, an outbreak of mild to severe respiratory illnesses occurred among thousands of young children in the United States, of which 1116 cases have been confirmed to be caused by EV-D68. This virus has also been associated with occasional neurological infections (12) . Although EV-D68 has emerged as a considerable global public health threat, there is no available vaccine or effective antiviral treatment.
The capsids of EVs consist of 60 copies of each of four different viral proteins: VP1, VP2, VP3, and VP4 (Fig. 1A) . Of these, VP1 (about 300 amino acids), VP2 (about 260 amino acids), and VP3 (about 240 amino acids) each have a "jelly roll" fold arranged in the capsid with pseudo T = 3 icosahedral symmetry, where T represents the triangulation number (13) . Their organization in the capsid is similar to that of the T = 3 RNA plant viruses, except that the three subunits related by quasi-threefold symmetry have different amino acid sequences in picornaviruses (6, 10) . Each roughly 70-amino-acids-long VP4 molecule forms an extended peptide on the internal surface of the capsid shell. The jelly roll fold consists of two antiparallel b sheets, which face each other to form a b barrel with a hydrophobic interior (Fig. 1B) .
EVs have a deep surface depression ("canyon") circulating around each of the 12 pentameric vertices (Fig. 1A) . The canyon was predicted to be the site of receptor binding, because the amino acids outside the canyon that form the external surface of the virus were more exposed and were shown to be accessible to neutralizing antibodies (Fig. 1A) (10, 14) . The virus thus could remain faithful to a specific receptor molecule that binds into the canyon while evading the host's immune system (10, 15) . The prediction that the canyon would be the site of binding to cellular receptor molecules was subsequently confirmed for numerous different EVs (16, 17) . All of the receptor
